|
Volumn 48, Issue TOPIC T1, 2001, Pages 25-31
|
Activity of telithromycin, a new ketolide antibacterial, against atypical and intracellular respiratory tract pathogens
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
AZITHROMYCIN;
CETHROMYCIN;
CLARITHROMYCIN;
CLINDAMYCIN;
DALFOPRISTIN PLUS QUINUPRISTIN;
DOXYCYCLINE;
EPEREZOLID;
ERYTHROMYCIN;
GATIFLOXACIN;
GEMIFLOXACIN;
JOSAMYCIN;
KETOLIDE;
LEVOFLOXACIN;
LINEZOLID;
MACROLIDE;
MINOCYCLINE;
MOXIFLOXACIN;
OFLOXACIN;
PEFLOXACIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFAMPICIN;
RIFAPENTINE;
ROXITHROMYCIN;
SODIUM CHLORIDE;
SPIRAMYCIN;
TELITHROMYCIN;
TETRACYCLINE;
UNINDEXED DRUG;
WATER;
ACCURACY;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIBIOTIC RESISTANCE;
ARTICLE;
CHLAMYDIA;
CLINICAL FEATURE;
CONTROLLED STUDY;
COST;
DRUG ACTIVITY;
DRUG DESIGN;
DRUG STRUCTURE;
GUINEA PIG;
LEGIONELLA;
MYCOPLASMA PNEUMONIA;
MYCOPLASMA PNEUMONIAE;
NONHUMAN;
PATHOGENICITY;
PNEUMONIA;
PREDICTION;
RADIOLOGY;
RESPIRATORY TRACT INFECTION;
TIME;
|
EID: 0034763652
PISSN: 03057453
EISSN: None
Source Type: Journal
DOI: 10.1093/jac/48.suppl_2.25 Document Type: Article |
Times cited : (45)
|
References (32)
|